Zogenix, Inc. (ZGNX)


NasdaqGM - NasdaqGM Real Time Price. Currency in USD
11.27+0.73 (+6.93%)
As of 3:41 PM EDT. Market open.
People also watch:
GALESNTASGYPAVEOCPRX
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open10.60
Prev Close10.54
Bid11.27 x 900
Ask11.30 x 300
Day's Range10.34 - 11.30
52wk Range7.33 - 16.56
1y Target EstN/A
Market Cap279.39M
P/E Ratio (ttm)-5.19
Beta1.76
Volume269,747
Avg Vol (3m)153,910
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • GlobeNewswire8 days ago

    Zogenix to Participate in Two Upcoming Investor Conferences

    EMERYVILLE, Calif., Sept. 20, 2016-- Zogenix, Inc., a pharmaceutical company developing therapies for the treatment of orphan and central nervous system disorders, today announced that Stephen J. Farr, ...

  • Capital Cube13 days ago

    ETF’s with exposure to Zogenix, Inc. : September 15, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to Zogenix, Inc. Here are 5 ETF’s with the largest exposure to ZGNX-US. Comparing the performance and risk of Zogenix, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • GlobeNewswire20 days ago

    Zogenix to have Significant Presence at 12th European Congress on Epileptology

    EMERYVILLE, Calif., Sept. 08, 2016-- Zogenix, Inc., a pharmaceutical company developing therapies for the treatment of orphan and central nervous system disorders, today announced that the Company is sponsoring ...